It has been determined that one of the studies used by the Centers for Disease Control (CDC) to justify the strict new mask mandates was not only rejected by peer review, but was also based on a vaccine that is currently not authorized for use in the United States, the Daily Caller reports.
The controversial study came from India, where scientists there studied “breakthrough infections” in over 100 healthcare workers who had received a vaccine but still caught the coronavirus, determining that the COVID-19 India variant, also known as the “Delta” variant, produces a higher viral load than other strains of the coronavirus. This was one of the pieces of evidence used by the CDC to claim that even vaccinated individuals should wear masks, since the India variant is allegedly capable of being transmitted by vaccinated individuals to unvaccinated individuals.
Despite admitting that the study in question involved a vaccine that has not been approved in the United States, the CDC’s report said that such studies “have noted relatively high viral loads and larger cluster sizes associated with infections with Delta, regardless of vaccination status. These early data suggest that breakthrough Delta infections are transmissible.”
But, in addition to relying on a vaccine that is different from the ones being used en masse in the United States, the study was also rejected upon peer review, and as a result is undergoing a revision.
Although it has been documented that vaccinated individuals can still catch the coronavirus, the notion of “asymptomatic spread” – the idea that an individual who is immune or displays no symptoms, despite actually possessing the virus, can still infect others – was debunked months ago. Yet this theory serves as the basis for the CDC’s abrupt new restrictions, issued on Tuesday; among other sudden reversals, the CDC now demands that all students in K-12 schools wear masks at all times, regardless of vaccination status, and that even unvaccinated people should continue wearing masks.